Eftychia Koumarianou1, Tatiana A Slastnikova2, Marek Pruszynski1, Andrey A Rosenkranz2, Ganesan Vaidyanathan1, Alexander S Sobolev2, Michael R Zalutsky3. 1. Department of Radiology, Duke University Medical Center, Durham, NC, USA. 2. Laboratory of Molecular Genetics of Intracellular Transport, Institute of Gene Biology, Moscow, Russia; Department of Biophysics, Faculty of Biology, Lomonosov Moscow State University, Moscow, Russia. 3. Department of Radiology, Duke University Medical Center, Durham, NC, USA; Departments of Biomedical Engineering and Radiation Oncology, Duke University, Durham, NC, USA. Electronic address: zalut001@mc.duke.edu.
Abstract
INTRODUCTION: Modular nanotransporters (MNTs) are vehicles designed to transport drugs from the cell surface via receptor-mediated endocytosis and endosomal escape to nucleus. Hence their conjugation to Auger electron emitters, can cause severe cell killing, by nuclear localization. Herein we evaluate the use of MNT as a platform for targeted radiotherapy with (67)Ga. METHODS: EGF was the targeting ligand on the MNT, and NOTA was selected for its radiolabeling with (67)Ga. In the radiolabeling study we dealt with the precipitation of MNT (pI 5.7) at the labeling pH (4.5-5.5) of (67)Ga. Cellular and nuclei uptake of (67)Ga-NOTA-MNT by the A431 cell line was determined. Its specific cytotoxicity was compared to that of (67)Ga-EDTA, (67)Ga-NOTA-BSA and (67)Ga-NOTA-hEGF, in A431 and U87MGWTT, cell lines, by clonogenic assay. Dosimetry studies were also performed. RESULTS: (67)Ga-NOTA-MNT was produced with 90% yield and specific activity of 25.6mCi/mg. The in vitro kinetics revealed an increased uptake over 24h. 55% of the internalized radioactivity was detected in the nuclei at 1h. The cytotoxicity of (67)Ga-NOTA-MNT on A431 cell line was 17 and 385-fold higher when compared to non-specific (67)Ga-NOTA-BSA and (67)Ga-EDTA. While its cytotoxic potency was 13 and 72-fold higher when compared to (67)Ga-NOTA-hEGF in the A431 and the U87MGWTT cell lines, respectively, validating its nuclear localization. The absorbed dose, for 63% cell killing, was 8Gy, confirming the high specific index of (67)Ga. CONCLUSION: These results demonstrate the feasibility of using MNT as a platform for single cell kill targeted radiotherapy by Auger electron emitters.
INTRODUCTION: Modular nanotransporters (MNTs) are vehicles designed to transport drugs from the cell surface via receptor-mediated endocytosis and endosomal escape to nucleus. Hence their conjugation to Auger electron emitters, can cause severe cell killing, by nuclear localization. Herein we evaluate the use of MNT as a platform for targeted radiotherapy with (67)Ga. METHODS:EGF was the targeting ligand on the MNT, and NOTA was selected for its radiolabeling with (67)Ga. In the radiolabeling study we dealt with the precipitation of MNT (pI 5.7) at the labeling pH (4.5-5.5) of (67)Ga. Cellular and nuclei uptake of (67)Ga-NOTA-MNT by the A431 cell line was determined. Its specific cytotoxicity was compared to that of (67)Ga-EDTA, (67)Ga-NOTA-BSA and (67)Ga-NOTA-hEGF, in A431 and U87MGWTT, cell lines, by clonogenic assay. Dosimetry studies were also performed. RESULTS: (67)Ga-NOTA-MNT was produced with 90% yield and specific activity of 25.6mCi/mg. The in vitro kinetics revealed an increased uptake over 24h. 55% of the internalized radioactivity was detected in the nuclei at 1h. The cytotoxicity of (67)Ga-NOTA-MNT on A431 cell line was 17 and 385-fold higher when compared to non-specific (67)Ga-NOTA-BSA and (67)Ga-EDTA. While its cytotoxic potency was 13 and 72-fold higher when compared to (67)Ga-NOTA-hEGF in the A431 and the U87MGWTT cell lines, respectively, validating its nuclear localization. The absorbed dose, for 63% cell killing, was 8Gy, confirming the high specific index of (67)Ga. CONCLUSION: These results demonstrate the feasibility of using MNT as a platform for single cell kill targeted radiotherapy by Auger electron emitters.
Authors: Michael R Zalutsky; Abraham Boskovitz; Chien-Tsun Kuan; Charles N Pegram; Joanne Ayriss; Carol J Wikstrand; Anne F Buckley; Eric S Lipp; James E Herndon; Roger E McLendon; Darell D Bigner Journal: Nucl Med Biol Date: 2011-09-29 Impact factor: 2.408
Authors: Dinara G Gilyazova; Andrey A Rosenkranz; Pavel V Gulak; Vladimir G Lunin; Olga V Sergienko; Yuri V Khramtsov; Kirill N Timofeyev; Mikhail A Grin; Andrey F Mironov; Andrey B Rubin; Georgii P Georgiev; Alexander S Sobolev Journal: Cancer Res Date: 2006-11-01 Impact factor: 12.701
Authors: Jean-Pierre Pouget; Lore Santoro; Laure Raymond; Nicolas Chouin; Manuel Bardiès; Caroline Bascoul-Mollevi; Helena Huguet; David Azria; Pierre-Olivier Kotzki; Monique Pèlegrin; Eric Vivès; André Pèlegrin Journal: Radiat Res Date: 2008-08 Impact factor: 2.841
Authors: Paul Chen; Judy Wang; Kristin Hope; Liqing Jin; John Dick; Ross Cameron; Joseph Brandwein; Mark Minden; Raymond M Reilly Journal: J Nucl Med Date: 2006-05 Impact factor: 10.057
Authors: Rhona Stein; Serengulam V Govindan; M Jules Mattes; Susan Chen; Linda Reed; Guy Newsome; Bill J McBride; Gary L Griffiths; Hans J Hansen; David M Goldenberg Journal: Cancer Res Date: 2003-01-01 Impact factor: 12.701
Authors: A A Rosenkranz; T A Slastnikova; Yu V Khramtsov; T S Karyagina; G P Georgiev; A S Sobolev Journal: Dokl Biochem Biophys Date: 2017-05-17 Impact factor: 0.788
Authors: Muhamad Faiz Bin Othman; Elise Verger; Ines Costa; Meena Tanapirakgul; Margaret S Cooper; Cinzia Imberti; Valerie J Lewington; Philip J Blower; Samantha Y A Terry Journal: Nucl Med Biol Date: 2019-12-13 Impact factor: 2.408
Authors: Tatiana A Slastnikova; Andrey A Rosenkranz; Yuri V Khramtsov; Tatiana S Karyagina; Sergey A Ovechko; Alexander S Sobolev Journal: Drug Des Devel Ther Date: 2017-04-26 Impact factor: 4.162
Authors: Tatiana A Slastnikova; Andrey A Rosenkranz; Natalia B Morozova; Maria S Vorontsova; Vasiliy M Petriev; Tatiana N Lupanova; Alexey V Ulasov; Michael R Zalutsky; Raisa I Yakubovskaya; Alexander S Sobolev Journal: Int J Nanomedicine Date: 2017-01-10
Authors: Andrey A Rosenkranz; Tatiana A Slastnikova; Tatiana A Karmakova; Maria S Vorontsova; Natalia B Morozova; Vasiliy M Petriev; Alexey S Abrosimov; Yuri V Khramtsov; Tatiana N Lupanova; Alexey V Ulasov; Raisa I Yakubovskaya; Georgii P Georgiev; Alexander S Sobolev Journal: Front Pharmacol Date: 2018-11-19 Impact factor: 5.810
Authors: Elise Verger; Jordan Cheng; Vittorio de Santis; Madeleine Iafrate; Jessica A Jackson; Cinzia Imberti; Gilbert O Fruhwirth; Philip J Blower; Michelle T Ma; Daniel R Burnham; Samantha Y A Terry Journal: Nucl Med Biol Date: 2021-06-15 Impact factor: 2.408